Clinical Trial Update: Study of a New Technique for Imaging Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a novel imaging technique for pancreatic cancer has completed, including tumors expressing the CA19-9 biomarker.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pancreatic Cancer, Tumors That Express CA19-9 | Phase 1 | Status: COMPLETED